FR2335222B1 - - Google Patents

Info

Publication number
FR2335222B1
FR2335222B1 FR7638152A FR7638152A FR2335222B1 FR 2335222 B1 FR2335222 B1 FR 2335222B1 FR 7638152 A FR7638152 A FR 7638152A FR 7638152 A FR7638152 A FR 7638152A FR 2335222 B1 FR2335222 B1 FR 2335222B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7638152A
Other languages
French (fr)
Other versions
FR2335222A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2335222A1 publication Critical patent/FR2335222A1/fr
Application granted granted Critical
Publication of FR2335222B1 publication Critical patent/FR2335222B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
FR7638152A 1975-12-17 1976-12-17 Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant Granted FR2335222A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51688/75A GB1573503A (en) 1975-12-17 1975-12-17 Clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
FR2335222A1 FR2335222A1 (fr) 1977-07-15
FR2335222B1 true FR2335222B1 (ja) 1982-06-11

Family

ID=10461003

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7638152A Granted FR2335222A1 (fr) 1975-12-17 1976-12-17 Derives etherifies de l'acide clavulanique, leur preparation et compositions therapeutiques en contenant

Country Status (10)

Country Link
JP (1) JPS5293792A (ja)
AU (1) AU2064576A (ja)
BE (1) BE849475A (ja)
DE (1) DE2657048A1 (ja)
DK (1) DK565676A (ja)
FR (1) FR2335222A1 (ja)
GB (1) GB1573503A (ja)
NL (1) NL7613965A (ja)
SE (1) SE7614181L (ja)
ZA (1) ZA767496B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5359690A (en) * 1976-09-09 1978-05-29 Glaxo Lab Ltd Production of novel betaa lactam
GB1587612A (en) * 1976-10-30 1981-04-08 Beecham Group Ltd Isoclavulanic acid derivatives
GB1595176A (en) * 1976-12-03 1981-08-12 Beecham Group Ltd Clavulanic acid ethers
IL53465A (en) * 1976-12-11 1980-11-30 Beecham Group Ltd Process for the preparation of clavulanic acid ethers and some novel compounds of this type
NO771106L (no) * 1977-03-10 1978-09-12 Beecham Group Ltd Fremgangsmaate for fremstilling av etere
EP0024123B1 (en) * 1979-08-11 1983-03-16 Beecham Group Plc Process for the preparation of derivatives of clavulanic acid
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
GB1573503A (en) 1980-08-28
NL7613965A (nl) 1977-06-21
JPS5293792A (en) 1977-08-06
BE849475A (fr) 1977-06-16
FR2335222A1 (fr) 1977-07-15
DE2657048A1 (de) 1977-06-23
DK565676A (da) 1977-06-18
AU2064576A (en) 1978-06-22
ZA767496B (en) 1978-02-22
SE7614181L (sv) 1977-06-18

Similar Documents

Publication Publication Date Title
FR2335222B1 (ja)
JPS5411451B2 (ja)
JPS5514113B2 (ja)
JPS5188079A (ja)
JPS5179796U (ja)
JPS5213753U (ja)
JPS567612Y2 (ja)
JPS5531214Y2 (ja)
JPS556590Y2 (ja)
JPS5194399U (ja)
JPS5197424A (ja)
JPS5218797U (ja)
JPS5254807U (ja)
JPS5263476U (ja)
JPS51158640U (ja)
JPS51113716U (ja)
CH595293A5 (ja)
CH583020A5 (ja)
CH588682A5 (ja)
CH589948A5 (ja)
CH591910A5 (ja)
CH591949A5 (ja)
CH592735A5 (ja)
CH594468A5 (ja)
CH595806A5 (ja)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse